AbbVie Inc.
BG ˙ BUL ˙ US00287Y1091
SecurityBG:4AB / AbbVie Inc.
InstitutionCapital Wealth Planning, LLC
Latest Disclosed Ownership57,056 shares
Latest Disclosed Value $ 12,409,150
Capital Wealth Planning, LLC reports 59.29% increase in ownership of 4AB / AbbVie Inc.

On May 15, 2026 - Capital Wealth Planning, LLC filed a 13F-HR form disclosing ownership of 57,056 shares of AbbVie Inc. (BG:4AB) valued at $12,409,150 USD as of March 31, 2026. The entity filed a previous 13F-HR on February 11, 2026 disclosing 35,818 shares of AbbVie Inc.. This represents a change in shares of 59.29% during the quarter.

Institutional Ownership: 13F and NPORT Filings

The Security and Class in the table below are shown exactly as filed by the investor. We do our best to track continuity of investments through acquisitions, and this will be reflected in the table as changes in names. In addition to descriptive data, performance of the investment is shown over time. To calculate quarterly performance, we first calculate cost basis of the shares purchased during the quarter, then use that to calculate gross profit. Quarterly return is Gross Profit / Starting Portfolio value.

Note that cost basis is calculated and stored in thousands, so small quarterly changes in shares frequently result in a cost basis of zero.

Upgrade to unlock premium data and export to Excel .

Disclosed Equity Positions (from 13F/NPORT Filings)
File
Date		 Effective
Date		Form Security Class ID Avg Price
Paid (Est)		 Reported
Shares		 ΔShares ΔShares
(%)		 Reported
Value
(x1000)		 ΔValue
(%)		 Alloc
(%)		 ΔAlloc ΔAlloc (%) Cost Basis
(x1000)		 Unrealized
Gain/Loss
(x1000)
2026-05-15 2026-03-31 13F ABBVIE COM 00287Y109 57,056 21,238 59.29 12,409 51.63 0.0684
2026-02-11 2025-12-31 13F ABBVIE COM 00287Y109 35,818 35,818 8,184 0.0530
2025-08-07 2025-06-30 13F ABBVIE COM 00287Y109 0 -6,609 -100.00 0 -100.00
2025-05-12 2025-03-31 13F ABBVIE COM 00287Y109 6,609 -126 -1.87 1,385 15.72 0.0120
2025-02-05 2024-12-31 13F ABBVIE COM 00287Y109 6,735 -235 -3.37 1,197 -13.08 0.0111
2024-11-12 2024-09-30 13F ABBVIE COM 00287Y109 6,970 -1,512 -17.83 1,376 -5.36 0.0128
2024-08-09 2024-06-30 13F ABBVIE COM 00287Y109 8,482 -1,132 -11.77 1,455 -16.91 0.0152
2024-05-07 2024-03-31 13F ABBVIE COM 00287Y109 9,614 9,614 1,751 0.0187
2024-02-08 2023-12-31 13F ABBVIE COM 00287Y109 0 -2,022 -100.00 0 -100.00
2023-11-06 2023-09-30 13F ABBVIE COM 00287Y109 2,022 2,022 301 0.0037
2022-08-08 2022-06-30 13F ABBVIE COM 00287Y109 0 -1,259 -100.00 0 -100.00
2022-05-11 2022-03-31 13F ABBVIE COM 00287Y109 1,259 1,259 204 0.0041
2022-02-04 2021-12-31 13F ABBVIE COM 00287Y109 0 -2,287 -100.00 0 -100.00
2021-11-03 2021-09-30 13F ABBVIE COM 00287Y109 2,287 -828 -26.58 247 -29.63 0.0068
2021-08-03 2021-06-30 13F ABBVIE COM 00287Y109 3,115 -324 -9.42 351 -5.65 0.0099
2021-04-19 2021-03-31 13F ABBVIE COM 00287Y109 3,439 -617 -15.21 372 -17.33 0.0121
2021-01-25 2020-12-31 13F ABBVIE COM 00287Y109 4,056 -3,312 -44.95 450 -30.23 0.0173
2020-11-10 2020-09-30 13F ABBVIE COM 00287Y109 7,368 -959 -11.52 645 -21.15 0.0319
2020-08-14 2020-06-30 13F ABBVIE COM 00287Y109 8,327 -4,090 -32.94 818 -13.53 0.0466
2020-04-30 2020-03-31 13F ABBVIE COM 00287Y109 12,417 4,789 62.78 946 40.15 0.0596
2020-02-26 2019-12-31 13F ABBVIE COM 00287Y109 7,628 -2,382 -23.80 675 -12.22 0.0399
2019-11-12 2019-09-30 13F ABBVIE E 00287Y109 10,010 1,864 22.88 769 29.90 0.0488
2019-08-02 2019-06-30 13F ABBVIE E 00287Y109 8,146 8,146 -64.65 592 -55.49 0.0429
2015-11-13 2015-09-30 13F Abbvie E 00287Y109 0 -9,628 -100.00 0 -100.00
2015-08-13 2015-06-30 13F Abbvie E 00287Y109 9,628 -10,914 -53.13 647 -46.22 0.3862
2015-05-13 2015-03-31 13F Abbvie E 00287Y109 20,542 0 0.00 1,203 -10.56 0.6267
2015-02-13 2014-12-31 13F/A-1 Abbvie E 00287Y109 20,542 -2,500 -10.85 1,345 1.13 0.6273
2015-02-13 2014-12-31 13F Abbvie E 00287Y109 39,000 1,590
2014-11-17 2014-09-30 13F Abbvie E 00287Y109 23,042 3,514 17.99 1,330 20.69 0.5394
2014-08-20 2014-06-30 13F Abbvie E 00287Y109 19,528 9,900 102.83 1,102 122.63 0.4074
2014-05-16 2014-03-31 13F Abbvie E 00287Y109 9,628 -29,372 -75.31 495 -68.87 0.2131
2014-02-10 2013-12-31 13F Abbvie E 00287Y109 39,000 15,372 65.06 1,590 50.43 1.9208
2013-11-14 2013-09-30 13F Abbvie E 00287Y109 23,628 -15,372 -39.42 1,057 -34.43 0.4757
2013-11-14 2013-06-30 13F Abbvie E 00287Y109 39,000 39,000 1,612 1.2662
Legend
Shares
The total number of shares held by the institution at the end of the reporting period (the effective date). This is provided in the filing.
Value
The total value of the shares as of the effective date. This is provided in the filing.
Avg. Share Price
The weighted average share price of the shares held by the institution. We use FIFO accounting to determine this price
Class
This is the security class as indicated by the filer. There are a variety of values for this field. Common values include "EC" = equity common, "EP" - equity preferred
Allocation (%)
The percent of the institution's portfolio that this position represents. This is provided in NPORT filings. For 13F filings, we calculate it.
Change in Allocation
The change in allocation from the prior reporting period. This is calculated as current allocation - prior allocation.
Change in Allocation (%)
The percent change in allocation from the prior reporting period. This is calculated as (current allocation - prior allocation) / prior allocation.
Cost Basis
The total cost of the shares held. This is calculated as reported shares * avg. share price
Unrealized Gain/Loss
This is the market value of the position as of the effective date minus the cost basis.